"Buprenorphine Cuts Length of Stay Nearly in Half for Infants Withdrawing from Opioids"
There's promising news for newborns who were exposed to opioids in utero - withdrawal symptoms resolved earlier when treated with buprenorphine as opposed to morphine, according to a new study published in the New England Journal of Medicine. "The beauty of our results is that the drug is immediately readily available, unequivocally effective, non-invasive and safe. This could impact standard of care for and the financial cost of neonatal abstinence syndrome," said Michelle E. Ehrlich, MD, professor of neurology from Icahn School of Medicine at Mount Sinai, who had initiated research on buprenorphine.
- Michelle E. Ehrlich, MD, Professor, Pediatrics, Neurology, Professor, Genetics and Genome Sciences, Icahn School of Medicine at Mount Sinai